Entity Common Stock, Shares Outstanding of Eloxx Pharmaceuticals, Inc. from 31 Oct 2011 to 12 Mar 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Eloxx Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Oct 2011 to 12 Mar 2026.
  • Eloxx Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 12 Mar 2026 was 5,071,935.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Eloxx Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 5,071,935 12 Mar 2026 10-K 17 Mar 2026 2025 FY
Q3 2023 3,143,390 -83,512,831 -96% 08 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 2,752,774 -83,903,447 -97% 09 Aug 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 2,166,356 -84,486,733 -98% 27 Mar 2023 10-K 31 Mar 2023 2022 FY
Q3 2022 86,656,221 +403,856 +0.47% 08 Nov 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 86,656,221 +453,449 +0.53% 10 Aug 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 86,653,089 +46,438,222 +115% 25 Mar 2022 10-K 30 Mar 2022 2021 FY
Q3 2021 86,252,365 +46,099,482 +115% 03 Nov 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 86,202,772 +46,065,079 +115% 09 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 40,214,867 +96,386 +0.24% 08 Mar 2021 10-K 12 Mar 2021 2020 FY
Q3 2020 40,152,883 +150,229 +0.38% 02 Nov 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 40,137,693 +198,025 +0.5% 03 Aug 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 40,118,481 +4,093,059 +11% 01 Mar 2020 10-K 06 Mar 2020 2019 FY
Q3 2019 40,002,654 +4,877,810 +14% 01 Nov 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 39,939,668 +5,081,988 +15% 01 Aug 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 36,025,422 +2,598,184 +7.8% 03 May 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 35,860,114 +8,332,376 +30% 31 Dec 2018 10-K 14 Mar 2019 2018 FY
Q3 2018 35,124,844 -16,289,769 -32% 01 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 34,857,680 03 Aug 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 33,427,238 +6,506,682 +24% 07 May 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 27,527,738 +6,790,891 +33% 31 Dec 2017 10-K 16 Mar 2018 2017 FY
Q3 2017 51,414,613 +30,918,228 +151% 25 Sep 2017 10-K 13 Oct 2017 2017 FY
Q1 2017 26,920,556 +6,499,948 +32% 28 Apr 2017 10-Q 22 May 2017 2017 Q3
Q4 2016 20,736,847 +316,239 +1.5% 01 Feb 2017 10-Q 10 Feb 2017 2017 Q2
Q3 2016 20,496,385 +106,576 +0.52% 30 Sep 2016 10-K 13 Oct 2016 2016 FY
Q1 2016 20,420,608 +4,033,086 +25% 09 May 2016 10-Q 12 May 2016 2016 Q3
Q4 2015 20,420,608 +6,553,981 +47% 05 Feb 2016 10-Q 16 Feb 2016 2016 Q2
Q3 2015 20,389,809 +6,543,448 +47% 15 Sep 2015 10-K 09 Oct 2015 2015 FY
Q1 2015 16,387,522 +9,481,362 +137% 11 May 2015 10-Q 14 May 2015 2015 Q3
Q4 2014 13,866,627 +8,824,352 +175% 31 Jan 2015 10-Q 17 Feb 2015 2015 Q2
Q3 2014 13,846,361 -218,055,007 -94% 15 Sep 2014 10-K 29 Sep 2014 2014 FY
Q1 2014 6,906,160 -187,799,099 -96% 30 Apr 2014 10-Q 09 May 2014 2014 Q3
Q4 2013 5,042,275 -141,933,008 -97% 31 Jan 2014 10-Q 14 Feb 2014 2014 Q2
Q3 2013 231,901,368 +115,148,183 +99% 31 Aug 2013 10-K 11 Sep 2013 2013 FY
Q1 2013 194,705,259 +100,983,431 +108% 10 May 2013 10-Q 15 May 2013 2013 Q3
Q4 2012 146,975,283 +58,949,255 +67% 31 Jan 2013 10-Q 14 Feb 2013 2013 Q2
Q3 2012 116,753,185 +35,976,088 +45% 15 Sep 2012 10-K/A 26 Oct 2012 2012 FY
Q1 2012 93,721,828 30 Apr 2012 10-Q 14 May 2012 2012 Q3
Q4 2011 88,026,028 31 Jan 2012 10-Q 14 Feb 2012 2012 Q2
Q3 2011 80,777,097 31 Oct 2011 10-Q 14 Nov 2011 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.